All eight immune checkpoint genes were overexpressed in both GBM and LGG tumors (Figure 1), of which only HAVCR2 was significantly upregulated in both glioma types and PDCD1LG2 showed significant upregulation in GBM but not in LGG (p < 0.05). This evidence concerns the gene PDCD1LG2 and glioblastoma.